Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Carisma Therapeutics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 76 | 106 | +30 |
| Shares | 40.1M | 66.2M | +26.1M (+65.0%) |
| Value | $104.4M | $305.9M | +$201.6M (+193.1%) |
New holders (43)
Institutions that held Carisma Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (13)
Institutions that held Carisma Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Kingdon Capital Management, L.L.C. | 1,311,672 | $3.41M |
| HRT Financial LP | 379,285 | $986.0K |
| ExodusPoint Capital Management, LP | 262,181 | $682.0K |
| California Public Employees Retirement System | 251,351 | $654.0K |
| Qube Research & Technologies Ltd | 156,027 | $406.0K |
| Acadian Asset Management LLC | 151,902 | $396.0K |
| LMR Partners LLP | 100,994 | $263.0K |
| Capstone Investment Advisors, LLC | 44,977 | $117.0K |
| Balyasny Asset Management LLC | 43,690 | $114.0K |
| Squarepoint Ops LLC | 42,158 | $110.0K |
| Jefferies Group LLC | 21,800 | $56.7K |
| Creative Planning | 18,700 | $49.0K |
| Engineers Gate Manager LP | 17,400 | $45.0K |